MedRepublic, Inc.

MedRepublic, Inc. operates a secure marketplace connecting medical travelers with certified international doctors, ensuring transparent healthcare options through dedicated Care Coordinators. MedRepublic, Inc. specializes in facilitating international medical travel, established in 2015 in Venice, US.

The company's founders are Jay Crouch, Jonathan Edelheit, and Robert Page, with Robert Page currently serving as CEO. The company has completed a total of 2 deals, with its most recent deal occurring on December 1, 2016. In that round, MedRepublic raised USD 0. 8 mn led by Afore Capital, amounting to the total funds raised of USD 0.

8 mn. Pulse Protocol focuses on providing a secure marketplace for medical travelers seeking access to certified international doctors. The core offering includes pairing patients with dedicated Care Coordinators who assist them in navigating various healthcare options, aimed at enhancing transparency in pricing and quality of healthcare. Pulse Protocol serves a global clientele, connecting patients from North America, Europe, and Asia with medical services for a range of treatments from elective procedures to specialized surgeries.

Pulse Protocol generates revenue through transaction-based services for medical travelers. The business model emphasizes direct-to-consumer interactions, allowing patients to engage directly with the platform for tailored healthcare solutions. Revenue is derived from fees linked to the coordination of medical services, including consultations with international doctors and ongoing support from Care Coordinators, structured on a per-transaction basis or through service fees aligned with specific healthcare journeys. The pricing model is designed to be transparent, supporting the mission of clear healthcare costs.

The most recent funding round in December 2016, which raised USD 0. 8 mn, will be utilized to enhance MedRepublic's offerings and expand its services. Future initiatives include the development of new products aimed at improving user experience in medical travel. The company also plans to target expansion into additional geographic markets, enhancing its presence in Europe and Asia by the end of 2018.